Experimental studies in models of non-alcoholic steatohepatitis (NASH) and neurodegenerative diseases have demonstrated that caffeine downregulates toll-like receptor 4 (TLR4)-mediated signaling, a key initiator of innate immune responses. Here, TLR4 is linked to metabolic dysfunction-associated steatohepatitis.